The Proceedings of the American Thoracic Society 4:252-257 (2007)
© 2007 The American Thoracic Society doi: 10.1513/pats.200701-018AW
Immunomodulatory Roles of Surfactant Proteins A and DImplications in Lung Disease
Amy M. Pastva1,2,
Jo Rae Wright1 and
Kristi L. Williams1,3
1 Department of Cell Biology, 2 Division of Physical Therapy, Department of Community and Family Medicine, and 3 Department of Immunology, Duke University Medical Center, Durham, North Carolina
Correspondence and requests for reprints should be addressed to Kristi L. Williams, Ph.D., Department of Cell Biology, Box 3709, Duke University Medical Center, Durham, NC 27710. E-mail: klw{at}cellbio.duke.edu
ABSTRACT
Surfactant, a lipoprotein complex, was originally described for its essential role in reducing surface tension at the airliquid interface of the lung; however, it is now recognized as being a critical component in lung immune host defense. Surfactant proteins (SP)-A and -D are pattern recognition molecules of the collectin family of C-type lectins. SP-A and SP-D are part of the innate immune system and regulate the functions of other innate immune cells, such as macrophages. They also modulate the adaptive immune response by interacting with antigen-presenting cells and T cells, thereby linking innate and adaptive immunity. Emerging studies suggest that SP-A and SP-D function to modulate the immunologic environment of the lung so as to protect the host and, at the same time, modulate an overzealous inflammatory response that could potentially damage the lung and impair gas exchange. Numerous polymorphisms of SPs have been identified that may potentially possess differential functional abilities and may act via different receptors to ultimately alter the susceptibility to or severity of lung diseases.
Key Words: collectins innate immunity lung disease
This article has been cited by other articles:

|
 |

|
 |
 
J. E. Levitt, M. K. Gould, L. B. Ware, and M. A. Matthay
Analytic Review: The Pathogenetic and Prognostic Value of Biologic Markers in Acute Lung Injury
J Intensive Care Med,
May 1, 2009;
24(3):
151 - 167.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Moulakakis and C. Stamme
Role of clathrin-mediated endocytosis of surfactant protein A by alveolar macrophages in intracellular signaling
Am J Physiol Lung Cell Mol Physiol,
March 1, 2009;
296(3):
L430 - L441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Gram, S. Yang, M. Steiner, A. Somani, S. Hawgood, B. R. Blazar, A. Panoskaltsis-Mortari, and I. Y. Haddad
Simultaneous absence of surfactant proteins A and D increases lung inflammation and injury after allogeneic HSCT in mice
Am J Physiol Lung Cell Mol Physiol,
February 1, 2009;
296(2):
L167 - L175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. White, P. Kingma, T. Tecle, N. Kacak, B. Linders, J. Heuser, E. Crouch, and K. Hartshorn
Multimerization of Surfactant Protein D, but Not Its Collagen Domain, Is Required for Antiviral and Opsonic Activities Related to Influenza Virus
J. Immunol.,
December 1, 2008;
181(11):
7936 - 7943.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Garcia-Verdugo, A. Ravasio, E. G. de Paco, M. Synguelakis, N. Ivanova, J. Kanellopoulos, and T. Haller
Long-term exposure to LPS enhances the rate of stimulated exocytosis and surfactant secretion in alveolar type II cells and upregulates P2Y2 receptor expression
Am J Physiol Lung Cell Mol Physiol,
October 1, 2008;
295(4):
L708 - L717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Clement, S. E. Evans, C. M. Evans, D. Hawke, R. Kobayashi, P. R. Reynolds, S. J. Moghaddam, B. L. Scott, E. Melicoff, R. Adachi, et al.
Stimulation of Lung Innate Immunity Protects against Lethal Pneumococcal Pneumonia in Mice
Am. J. Respir. Crit. Care Med.,
June 15, 2008;
177(12):
1322 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Thoracic Society.
|
|
|